Skadden, Arps, Slate, Meagher & Flom (New York)

Neal R. Stoll

Skadden, Arps, Slate, Meagher & Flom (New York)
Lawyer (Partner)

Neal R. Stoll represents clients in connection with investigations conducted by the staff of the U.S. Department of Justice, Antitrust Division; Part 2 investigations conducted by the staffs of the Federal Trade Commission’s Bureau of Competition and Bureau of Consumer Protection; and Part 3 administrative proceedings and appeals. He also has federal trial and appellate experience in cases involving monopolization, distribution practices, the Robinson-Patman Act and acquisitions. Mr. Stoll counsels clients on antitrust issues stemming from mergers and acquisitions. For example, he represented BlackRock, Inc. in its $20 billion acquisition of Barclays Global Investors; Chevron Corporation in its $4.3 billion acquisition of Atlas Energy Inc.; Ecolab Inc. in its $8.1 billion acquisition of Nalco Holdings Company; Pactiv Corporation in its $6 billion acquisition by Reynolds Group Holdings Limited; CF Industries Holdings Inc. with its exchange offer for Terra Industries Inc. and CF Industries Holdings Inc. regarding Agrium Inc.’s unsolicited exchange offer; The Coca-Cola Company in its proposed acquisition of China Huiyuan Juice Group Limited; M&F Worldwide Corp. in its acquisition of John H. Harland Company; The May Department Store Company in connection with its merger with Federated Department Stores, Inc.; Guidant Corporation in connection with its proposed acquisitions by Johnson & Johnson and Boston Scientific; Caesars Entertainment, Inc. in connection with its merger with Harrah’s Entertainment, Inc.; and TRW Inc. in connection with its merger with Northrop Grumman Corporation. He also was lead counsel in United States v. The Gillette Compa­ny (acqui­sition of Parker Pen Ltd.), and United States v. Rank Organisation Plc (acqui­sition of Deluxe Film Labora­to­ries). In addition, he has han­dled the anti­trust matters relating to acquisitions and dispo­si­tions for The Milton Hershey Trust, MacAndrews & Forbes Group Incorpo­rated, Revlon Group Incorporated and Ball Corporation. Mr. Stoll also advises corporate clients on other anti­trust and consumer protection matters, including compli­ance programs and advice regarding the implementation of proposed business plans. He has advised a number of consumer product companies in connection with the imple­mentation of marketing and promotional business plans. Mr. Stoll has lectured for the Practicing Law Institute, the New York State and City Bar Associations, and has co-authored a treatise and more than 360 articles on antitrust and trade regulation matters. He repeatedly has been included in The Best Lawyers in America and Chambers USA: America’s Leading Lawyers for Business. In addition, he was selected for inclusion in Leaders in Their Field 2006.

Distinctions

Linked authors

Skadden, Arps, Slate, Meagher & Flom (London)
Skadden, Arps, Slate, Meagher & Flom (London)
Skadden, Arps, Slate, Meagher & Flom (London)
Skadden, Arps, Slate, Meagher & Flom (New York)
Skadden, Arps, Slate, Meagher & Flom (Brussels)

Articles

2636 Bulletin

Brian C. Mohr, Joseph P. Nisa, Matthew P. Hendrickson, Neal R. Stoll, Rita Sinkfield Belin, Steve Albertson The US FTC issues proposed rulemaking relating to withdrawal of Hart-Scott-Rodino filings

152

The Federal Trade Commission (FTC) recently issued a Notice of Proposed Rulemaking that, if adopted, will codify the FTC’s longstanding informal procedures for voluntarily withdrawing and refiling an HSR Act Premerger Notification and Report Form (HSR filing) and, more significantly, will (...)

Brian C. Mohr, Joseph P. Nisa, Matthew P. Hendrickson, Neal R. Stoll, Rita Sinkfield Belin The US FTC issues a statement to clarify the use of escrows in reportable acquisitions

174

On April 29, 2011, the Premerger Notification Office (PNO) of the Federal Trade Commission (FTC) issued a statement “to provide greater clarity about the use of escrows in connection with transactions” that require notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as (...)

Alec Y. Chang, Clifford H. Aronson, Ian G. John, Neal R. Stoll The US District Court for the Central District of California denies the FTC’s request for a preliminary injunction in a medical laboratory merger case (LabCorp / Westcliff)

212

In a decision broadly critical of the Federal Trade Commission’s case challenging the acquisition of Westcliff Medical Laboratories, Inc., a medical laboratory company, by Laboratory Corporation of America (LabCorp), Judge Andrew Guilford of the U.S. District Court for the Central District of (...)

Ian G. John, Neal R. Stoll, Steven C. Sunshine The US DoJ settles Hart-Scott-Rodino gun jumping charges stemming from buyer’s pre-approval of target’s purchasing contracts (Smithfield Foods / Premium Farms)

236

On January 21, 2010, after a three-year and four-month investigation, the Department of Justice (DOJ) announced a $900,000 settlement with meat processors Smithfield Foods Inc. and Premium Farms LLC to resolve DOJ allegations that Smithfield exercised operational control over Premium (...)

Gary A. MacDonald, James A. Keyte, Neal R. Stoll, Steven C. Sunshine The US FTC finalizes amendments to parts 3 and 4 of its rules of practice expediting administrative review of mergers

124

On April 27, 2009, the Federal Trade Commission adopted final rules amending Parts 3 and 4 of its Rules of Practice. The adoption of these rules is a culmination of efforts going back a couple of years to make changes that would expedite adjudications of allegedly anti-competitive merger (...)

Brian C. Mohr, Joseph P. Nisa, Neal R. Stoll, Rita Sinkfield Belin The US FTC imposes civil penalty for pre-merger filing violations related stock acquisitions (ValueAct)

143

The Federal Trade Commission earlier this week obtained a $1.1 million civil penalty against ValueAct Capital Partners, L.P. (“ValueAct”) for ValueAct’s failure to file the required Hart-Scott-Rodino (“HSR”) premerger notifications before acquiring additional shares of voting securities of (...)

Gary A. MacDonald, Jessica Biggio, Neal R. Stoll The US Court of Appeals for the Ninth Circuit applies a cost-based test to attempted monopolization claim premised on multiproduct discounting (Cascade Health Solutions / PeaceHealth)

228

The Ninth Circuit evaluated the antitrust implications of multiproduct or “bundled” discounts in Cascade Health Solutions v. PeaceHealth, CV-02-06032 (Sept. 4, 2007). In doing so, the Ninth Circuit rejected the controversial Third Circuit rule of LePage’s Inc. v. 3M, 324 F.3d 141 (3d Cir. 2003), (...)

Send a message